These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8993676)

  • 1. Solcoseryl stimulates behavioural activity of rats.
    Braszko JJ; Winnicka MM; Wiśniewski K
    Acta Physiol Hung; 1996; 84(1):63-72. PubMed ID: 8993676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central activity of 2-amino-4-phosphonobutyric acid (AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1995; 47(1):9-17. PubMed ID: 7550555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
    Amabeoku GJ
    Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solcoseryl improves learning and memory in rats.
    Winnicka MM; Braszko JJ; Wisniewski K
    Acta Physiol Hung; 1996; 84(1):55-62. PubMed ID: 8993675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural effect of Pavetta crassipes extract on rodents.
    Amos S; Akah PA; Enwerem N; Chindo BA; Hussaini IM; Wambebe C; Gamaniel K
    Pharmacol Biochem Behav; 2004 Apr; 77(4):751-9. PubMed ID: 15099920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central action of glucagon.
    Morawska D; Sieklucka-Dziuba M; Kleinrok Z
    Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R; Randrup A
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimation of central activity of hydroxyproline--the amino acid characteristic for collagen degradation products.
    Wiśniewski K; Lutostańska A; Artemowicz B; Maćkowiak J
    Pol J Pharmacol; 1995; 47(4):285-91. PubMed ID: 8616506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diphasic action of apomorphine on motility of the rat. I. Dose-effect relationship in exploratory and basal motility].
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):374-80. PubMed ID: 7236417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1996; 48(4):415-23. PubMed ID: 9112682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedative effects of the methanolic leaf extract of Newbouldia laevis in mice and rats.
    Amos S; Binda L; Vongtau H; Chindo B; Abbah J; Sambo N; Odin EM; Okwute SK; Akah P; Wambebe C; Gamaniel K
    Boll Chim Farm; 2002; 141(6):471-5. PubMed ID: 12577520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.